These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 24857865)
1. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM. Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865 [TBL] [Abstract][Full Text] [Related]
2. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320 [TBL] [Abstract][Full Text] [Related]
3. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET. Jarkas N; Voll RJ; Williams L; Goodman MM Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164 [TBL] [Abstract][Full Text] [Related]
4. [11C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET). Gourand F; Amini N; Jia Z; Stone-Elander S; Guilloteau D; Barré L; Halldin C PLoS One; 2015; 10(9):e0137160. PubMed ID: 26367261 [TBL] [Abstract][Full Text] [Related]
5. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Lundberg J; Odano I; Olsson H; Halldin C; Farde L J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534 [TBL] [Abstract][Full Text] [Related]
6. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent. Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117 [TBL] [Abstract][Full Text] [Related]
8. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. Jarkas N; Votaw JR; Voll RJ; Williams L; Camp VM; Owens MJ; Purselle DC; Bremner JD; Kilts CD; Nemeroff CB; Goodman MM Nucl Med Biol; 2005 Apr; 32(3):211-24. PubMed ID: 15820756 [TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study. Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands. Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744 [TBL] [Abstract][Full Text] [Related]
12. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging. Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858 [TBL] [Abstract][Full Text] [Related]
13. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM). Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271 [TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain. Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380 [TBL] [Abstract][Full Text] [Related]
15. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics. Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480 [TBL] [Abstract][Full Text] [Related]
16. One-step preparation of [(18)F]FPBM for PET imaging of serotonin transporter (SERT) in the brain. Qiao H; Zhang Y; Wu Z; Zhu L; Choi SR; Ploessl K; Kung HF Nucl Med Biol; 2016 Aug; 43(8):470-7. PubMed ID: 27236282 [TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study. Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552 [TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [ Majuri J; Joutsa J; Johansson J; Voon V; Parkkola R; Alho H; Arponen E; Kaasinen V Eur Neuropsychopharmacol; 2017 Dec; 27(12):1281-1288. PubMed ID: 29032922 [TBL] [Abstract][Full Text] [Related]
19. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study. Takano A; Halldin C; Farde L Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625 [TBL] [Abstract][Full Text] [Related]
20. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats. Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]